These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22734925)

  • 21. Obliteration of a Portosystemic Shunt by Hybrid Interventional Radiology Using a Transmesenteric Approach Under Minilaparotomy After Liver Transplantation: A Case Report.
    Fukuhara S; Ohira M; Chosa K; BaBa Y; Hamaoka M; Tanimine N; Morimoto H; Kuroda S; Tahara H; Ide K; Kobayashi T; Awai K; Ohdan H
    Transplant Proc; 2020 Nov; 52(9):2762-2766. PubMed ID: 32682578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
    Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of solitary gastric fundal varices and portosystemic encephalopathy accompanying liver cirrhosis by balloon-occluded retrograde transvenous obliteration (B-RTO): a case report.
    Ohmoto K; Miyake I; Tsuduki M; Ohno S; Yamamoto S
    Hepatogastroenterology; 1999; 46(26):1249-52. PubMed ID: 10370701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.
    Conn HO; Rössle M; Levy L; Glocker FX
    Scand J Gastroenterol; 2006 May; 41(5):619-25. PubMed ID: 16638707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
    Takashimizu S; Watanabe N; Kojima S; Kagawa T; Mine T; Myojin K; Koizumi J
    Tokai J Exp Clin Med; 2007 Jul; 32(2):70-4. PubMed ID: 21319062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt.
    Kako Y; Yamakado K; Jomoto W; Nasada T; Asada K; Takaki H; Kobayashi K; Daimon T; Hirota S
    Jpn J Radiol; 2017 Jul; 35(7):366-372. PubMed ID: 28501975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of a patient with idiopathic portal hypertension and hepatic encephalopathy.
    Ohta M; Shimada T; Matsufuji H; Yukizane T; Yamada H; Sugimachi K
    Hepatogastroenterology; 2001; 48(41):1461-3. PubMed ID: 11677987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt.
    Choi YH; Yoon CJ; Park JH; Chung JW; Kwon JW; Choi GM
    Korean J Radiol; 2003; 4(2):109-16. PubMed ID: 12845306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic intrahepatic portosystemic venous shunt: embolization with an alternative approach.
    Tanoue S; Kiyosue H; Komatsu E; Hori Y; Maeda T; Mori H
    AJR Am J Roentgenol; 2003 Jul; 181(1):71-8. PubMed ID: 12818832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein.
    Li W; Cui M; Li Q; Zhang K; Zhai S; Li T; Nick C; Li X; Wang H; Zhu Y; Lu D; Chen J
    J Interv Med; 2023 May; 6(2):90-95. PubMed ID: 37409061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils.
    Matsuoka S; Yamana Y; Ishii T; Kumagawa M; Mizutani T; Kamimura S; Matsumoto N; Nakamura H; Nirei K; Tatsuo K; Moriyama M
    Intern Med; 2018 Jul; 57(13):1861-1866. PubMed ID: 29491295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular plug-assisted retrograde transvenous obliteration of portosystemic shunts for refractory hepatic encephalopathy: a case report.
    Park JK; Cho SK; Kee S; Lee EW
    Case Rep Radiol; 2014; 2014():391420. PubMed ID: 24744943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transhepatic catheter-directed thrombolysis for portal vein thrombosis after partial splenic embolization in combination with balloon-occluded retrograde transvenous obliteration of splenorenal shunt.
    Nakai M; Sato M; Sahara S; Kawai N; Kimura M; Maeda Y; Ibata Y; Higashi K
    World J Gastroenterol; 2006 Aug; 12(31):5071-4. PubMed ID: 16937510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-Session Percutaneous Endovascular Mesocaval Shunt Creation and Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices.
    Srinivasa RN; Majdalany BS; Chick JFB; Meadows JM; Fenlon JB; Brewerton C; Saad WE
    Ann Vasc Surg; 2018 Jan; 46():371.e1-371.e6. PubMed ID: 28893712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Successful Control of Hyperammonemia with BRTO of a Splenorenal Shunt Induced by CAPOX Therapy].
    Hori Y; Irei T; Harada T; Yamashiro N; Motonari H; Kinjo N; Arakaki J; Samura H; Kameyama S; Nagamine Y; Kohakura F; Ishimine T; Tsuruta Y; Matsuzaki A
    Gan To Kagaku Ryoho; 2021 Dec; 48(12):1507-1510. PubMed ID: 34911920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional recovery from refractory hepatic encephalopathy following angiographic obliteration of a large, spontaneous portal-umbilical portosystemic shunt: a case report.
    Ngu NLY; Saxby E; Farmer CC; Lyon S; Le S
    CVIR Endovasc; 2022 Aug; 5(1):45. PubMed ID: 36002541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay of portal pressure, portal perfusion and hepatic arterial inflow in modulating expression of hepatic encephalopathy in patients with spontaneous or artificially created portosystemic shunts.
    Mullen KD
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S25-7. PubMed ID: 15025249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long-term outcomes in 14 patients.
    Naeshiro N; Kakizawa H; Aikata H; Kan H; Fujino H; Fukuhara T; Kobayashi T; Honda Y; Miyaki D; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Hyogo H; Ishikawa M; Awai K; Chayama K
    Hepatol Res; 2014 Jul; 44(7):740-9. PubMed ID: 23745735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.